Table 1.
Vehicle (N) | Acute Tx (N) | Delayed Tx (N) | |
---|---|---|---|
Acute vs delayed Tx | |||
SCI and cell Tx | 16 | 16 | 16 |
SC121 human cell stereology | N/A | 6 | 6 |
SC123 human astrocyte stereology | N/A | 6 | N/A |
Fibronectin lesion volume | 6 | 6 | N/A |
CatWalk gait analysis | 16 | 15 | N/A |
IgG2a (N) | Anti-Ly6G (N) | |
---|---|---|
PMN depletion study | ||
SCI only | 8 | 8 |
Acute Tx | ||
SCI and cell Tx | 12 | 12 |
Fibronectin lesion volume | 5 | 5 |
SC121 human cell stereology | 5 | 5 |
SC123 human astrocyte stereology | 5 | 5 |
SC121 cluster volume | 5 | 5 |
SC123 cluster volume | 5 | 5 |
CatWalk gait analysis | 10 | 10 |
Hargreaves | 10 | 10 |
Vehicle | ||
SCI and vehicle injection | 12 | 12 |
CatWalk gait analysis | 12 | 10 |
Hargreaves | 12 | 10 |
Tx, Transplantation.